LKY-047: First Selective Inhibitor of Cytochrome P450 2J2

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Drug Metabolism And Disposition

• Publication date

  2017-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.117.075036PMID 28461575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple Modes of Inhibition of Human Cytochrome P450 2J2 by Dronedarone, Amiodarone and their Active Metabolites

  2016cited by this paper
• Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.

  2015influential reference
• Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner

  2015cited by this paper
• Potential of 4′-(p-toluenesulfonylamide)-4-hydroxychalcone to inhibit the human cytochrome P450 2J2 isoform

  2014influential reference
• Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.

  2014influential reference
• CYP2J2 and CYP2C19 Are the Major Enzymes Responsible for Metabolism of Albendazole and Fenbendazole in Human Liver Microsomes and Recombinant P450 Assay Systems

  2013influential reference
• Discovery and Characterization of Novel, Potent, and Selective Cytochrome P450 2J2 Inhibitors

  2013influential reference
• CYP 2 J 2 and CYP 2 C 19 Are the Major Enzymes Responsible for Metabolism of Albendazole and Fenbendazole in Human Liver Microsomes and Recombinant P 450 Assay Systems

  2013cited by this paper
• Inhibitory Potential of Thelephoric Acid on CYP2J2 Activities in Human Liver Microsomes

  2013influential reference
• Inhibitory effect of honokiol and magnolol on cytochrome P450 enzyme activities in human liver microsomes

  2013cited by this paper
• Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity

  2012influential reference
• Potential of hydroxyebastine and terfenadine alcohol to inhibit the human cytochrome P450 2J2 isoform

  2011cited by this paper
• Screening of Potential Anticancer Compounds from Marketed Drugs: Aripiprazole, Haloperidol, Miconazole, and Terfenadine Inhibit Cytochrome P450 2J2

  2011cited by this paper
• Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity

  2011influential reference
• A qualitative approach to enzyme inhibition

  2009cited by this paper
• Characterization of Ebastine, Hydroxyebastine, and Carebastine Metabolism by Human Liver Microsomes and Expressed Cytochrome P450 Enzymes: Major Roles for CYP2J2 and CYP3A

  2006cited by this paper
• Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.

  2006cited by this paper
• Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

  2005cited by this paper
• High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.

  2005influential reference
• Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.

  2004cited by this paper
• Reaction phenotyping in drug discovery: moving forward with confidence?

  2003cited by this paper
• (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.

  2002cited by this paper
• Cytochrome P450 pathways of arachidonic acid metabolism

  2002cited by this paper
• Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine.

  2001cited by this paper
• Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids*

  2001cited by this paper
• High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.

  2000cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady‐state enzyme systems. Author: Irwin H. Segal (University of California, Davis). Published by Wiley‐Interscience, New York, 1975. Price: $24.50. No. of pages: 957

  1976cited by this paper
• Book Review:Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. Irwin H. Segel

  1976cited by this paper

• Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis.

  2025cites this paper
• Anticancer potential of decursin, decursinol angelate, and decursinol from Angelica gigas Nakai: A comprehensive review and future therapeutic prospects

  2024cites this paper
• CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.

  2024cites this paper
• Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review

  2024cites this paper
• Bilobetin induces apoptosis in human hepatocellular carcinoma cells via ROS level elevation and inhibition of CYP2J2

  2023cites this paper
• Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation

  2022cites this paper
• Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1

  2022cites this paper
• Addressing Today’s Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam

  2021cites this paper
• LINEZOLID METABOLISM IS CATALYZED BY CYP2J2, CYP4F2 AND CYP1B1 Linezolid Metabolism by CYP2J2, CYP4F2, and CYP1B1 non-transfected

  2021cites this paper
• Addressing Today ’ s Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam S

  2021cites this paper
• Cytochrome P450 Inhibition

  2020cites this paper
• CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.

  2020cites this paper
• Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications.

  2020cites this paper
• Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.

  2019cites this paper
• Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms

  2019cites this paper
• Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography–tandem mass spectrometry

  2019cites this paper